Ligand Pharma (LGND) Reports Mixed Q4 Results; FY11 Revs Guidance Light
Tweet Send to a Friend
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) reported Q4 EPS of $0.12 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
